DSpace at RU >

Search Results

Results 1-4 of 4.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2010	High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue.	Tol, J.; Dijkstra, J.R.; Vink-Borger, M.E.; Nagtegaal, I.D.; Punt, C.J.A.; Krieken, J.H.J.M. van; Ligtenberg, M.J.L.
	2010	Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab.	Tol, J.; Dijkstra, J.R.; Klomp, M.; Teerenstra, S.; Dommerholt, M.; Vink-Borger, M.E.; Cleef, P.H. van; Krieken, J.H.J.M. van; Punt, C.J.A.; Nagtegaal, I.D.
	2009	COL3A1 2209G>A is a predictor of pelvic organ prolapse.	Kluivers, K.B.; Dijkstra, J.R.; Hendriks, J.C.M.; Lince, S.L.; Vierhout, M.E.; Kempen, L.C.L.T. van
	2009	Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.	Tol, J.; Koopman, M.; Cats, A.; Rodenburg, C.J.; Creemers, G.J.; Schrama, J.G.; Erdkamp, F.L.; Vos, A.H.; Groeningen, C.J. van; Sinnige, H.A.M.; Richel, D.J.; Voest, E.E.; Dijkstra, J.R.; Vink-Borger, M.E.; Antonini, N.F.; Mol, L.; Krieken, J.H.J.M. van; Dalesio, O.; Punt, C.J.A.

1